830
Views
60
CrossRef citations to date
0
Altmetric
Review

The selection of high-producing cell lines using flow cytometry and cell sorting

&
Pages 1821-1829 | Published online: 23 Feb 2005

Bibliography

  • KOHLER G, MILSTEIN C: Continuousculture of fused cells secreting antibody of predefined specificity. Nature (1975) 256:495–497.
  • WIRTH M, REHM H, REED G,PUHLER A, STADLER P: Genetic engineering of animal cells. In:Biotechnology Volume 2 Genetic Engineering and Genetic Fundamentals. Puhler A (Ed.), Wiley-VCH (1993):63–744.
  • •Review of screening methods available for the selection of high-producing clones.
  • KIM NS, KIM SJ, LEE GM: Clonalvariability within dihydrofloate reductase-mediated gene amplified Chinese hamster ovary cells: Stability in the absence of selective pressure. Biotechnol. Bioeng. (1998) 60:679–688.
  • BARNES LM, BENTLEY C,DICKSON AJ: Characterisation of the stability of recombinant protein production in the GS-N50 expression system. Biotechnol Bioeng. (2001) 73(4):261–270.
  • •Reported instability in a recombinant glutamine synthetase-NSO cell line after 30 days of culturing.
  • KAUFMAN R, SHARP PA: Amplification and expression of sequences cotransfected with modular dihydrofolate reductase DNA gene.' Ma Biol. (1982) 159:601–621.
  • BEBBINGTON CR, RENNER G, THOMSON S, KING D, ABRAMS D, YARRANTON GT: High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 6V/9 (1992) 10:169–175.
  • •Introduced glutamine synthetase-selectable marker into a myeloma and amplified the vector using methionine sulfoxirnine (NISX).
  • GU MB, KERN JA, TODD P, KOMPALA S: Effect of amplification of dhfr and lac Z genes on growth and P-galactosidase expression in suspension cultures of recombinant CHO cell. Cytotechnology (1992) 9:237–245.
  • PENDSE GJ, KARKARES S, BAILEY JE: Effect of cloned gene dosage on cell-growth and hepatitis-B surface-antigen synthesis and secretion in recombinant CHO cells. Biotechnol Bioeng. (1992) 40(1):119–129.
  • KROMENAKER SJ, SRIENC F: Stability of producer hybridoma cell lines after cellsorting: a case study. Biotechnol Frog. (1994) 10:299–307.
  • KIM SJ, KIM NS, RYU CJ, HONG HJ, LEE GM: Characterisation of chimeric producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure.Biotechnol Bioeng. (1998) 58:73–84.
  • •Examined the stability ofrecombinant CHO cells during gene amplification using MSX.
  • FRAME KK, HU W-S: The loss of antibody productivity in continuous culture of hybridoma cells. Biotechnol. Bioeng. (1990) 35:469–476.
  • BORTH N, ZEYDA M, KATINGER H: Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting. Biotechnol Bioeng. (2001) 71(4):266–273.
  • ••Selected high-producing recombinantCHO cells using a biotin/avidin affinity matrix. The specific antibody production rate of the clone selected using this technique was five times higher than that of the clone obtained using limiting dilution cloning.
  • CUNNINGHAM R: Overview of fluorescent probes for cytometry. In:Methods M Molecular Biology Vol. 115 Immunocytochemical Methods and Protocols.Javois LC (Ed), Humana Press, Inc., Totowa, NJ, USA (1999):249–259.
  • RADCLIFF G, JAROSZESKI MJ: Basics of flow cytometry. In: Methods M Molecular Biology Vol. 91: Plow Cytometry Protocols.Jaroszeski MJ, Heller R (Eds), Humana Press Inc., New Jersey, USA (1988):1–24.
  • DEAN PN: Helpful hints in flow cytometry and sorting. Cytometry (1985) 6:62–64.
  • BATTYYE FL, LIGHT A,TARLINGTON DM: Single cell sorting and cloning. I Immunol Methods (2000) 243:25–32.
  • PARKS DR, BRYAN VM, OI VT, HERZENBERG LA: Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc. Natl. Acad. Sci. USA (1979) 76:1962–1966.
  • ••Describes labelling of hybridomas withfluorescent microspheres coupled with antigens, and cloning of these using a fluorescence-activated cell sorter.
  • DANGL J, HERZENBERG L: Selection ofhybridomas and hybridoma variants usingthe fluorescence activated cell sorter. .1 Immunol Methods (1982) 52:1–14.
  • MARTEL F, BAZIN R, VERETTE S, LEMIEUX R: Characterisation of higher avidity monoclonal antibodies produced by murine B-cell hybridoma variants selected for increased antigen binding of membrane IgG. Immunol (1988) 141:1624–1629.
  • JANTSCHEFF P, WINKLER L, KARAWAJEW L, KAISER G, BOTTEGER V, MICHEEL B: Hybrid hybridomas producing bispecific antibodies to CEA and perwddase by a combination of HAT medium selection and fluorescence activated cell sorting. I Immunol Methods (1993) 163:91–97.
  • KAVATHAS P, HERZENBERG LA: Amplification of a gene coding for human T-cell differentiation antigen. Nature (1983) 306:385–387.
  • BECKERS T, HAUSER H, HUSKEN D, ENGELS JW: Expression and characterisation of a des-methionine mutant interleukin receptor (tac protein) with interleukin-2 binding affinity. j. Biol. Chem. (1988) 263:8359–8365.
  • STRAIR RK, TOWLE MJ, SMITH BR: Recombinant retroviruses encoding cell surface antigens as selectable markers. .1 Viral. (1998) 62:4765–4759.
  • JOHNSTON RN, BEVERLY SM, SCHINKE RT: Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence activated cell sorting. Proc. Nati Acad. Sci. USA (1983) 80:3711–3715.
  • KAUFFMAN RJ, MURTHA P: Translational control mediated by eukaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells. Ma Cell. Biol. (1987) 2:1568–1571.
  • HEATH C, DILWITH R, BELFORT G: Methods for increasing antibody production in suspension and entrapped cell culture: Biochemical and flow cytometric analysis as a function of medium serum content. Biotechnol (1990) 15:71–90.
  • COUTURE ML, HEATH CA: Relationship between the loss of heavy chains and the appearance of nonproducing hybridomas. Biotechnol Bioeng. (1995) 47:270–275.
  • BORTH N, STRUTZENBERGER K, DONALIES U, KUNERT R, KATINGER H: Comparison of the production of a human monoclonal antibody against HIV-1 by heterohybridoma cells and recombinant CHO cells: A flow cytometric study. Cytotechnology (1996) 22:129–138.
  • STRUTZENBERGER K, BORTH N, KUNERT R, STEINFELLNER W, KATINGER H: Changes during subclone development and ageing of human antibody-producing recombinant CHO cells. J. Biotechnol (1999) 69:215–226.
  • •Reported on gene copy number and site of chromosomal integration of heavy and light chain antibody-producing genes in a recombinant CHO cell.
  • MARDER P, MACIACK RS, FOUTS RL, BAKER RS, STARLING JJ: Selective cloning of hybridoma cells for enhanced immunoglobulin production using flow cytometric cell sorting and automated laser nephelometry. Cytometry (1990) 11(4):498–505.
  • SEN S, HU WS, SRIENC F: Flow cytometric study of hybridoma cell culture: correlation between cell surface fluorescence and IgG production rate. Enzyme Microb. Technol (1990) 12:571–576.
  • MCKINNEY KL, DILWITH R, BELFORT G: Manipulation of heterogeneous hybridoma cultures for overproduction of monoclonal-antibodies. Biotechnol Frog. (1991) 7(5):445–454.
  • •Sorted high-producing hybridoma clones using cell surface fluorescence and cell sorting. Found a positive correlation between cell surface fluorescence and specific antibody secretion.
  • CHERLET M, KROMENAKER SJ, SRIENC F: Surface IgG content of murine hybridomas-direct evidence for a variation of antibody secretion rates during the cell cycle. Biotechnol Bioeng. (1995) 47(5):535–540.
  • WEAVER JC, WILLIAMS GB, KILBANOV A, DEMAIN AL: Gel Microdroplets: a rapid detection and enumeration of individual microorganisms by their metabolic activity. Biotechnology o119 (1988) 6:1084–1089.
  • POWELL KT, WEAVER JC: Gel microdroplets and flow cytometry: rapid determination of antibody secretion by individual cells within a cell population. Biotechnology o119 (1990) 8:333–337.
  • ••First report of GMD secretion assay toselect hybridoma cells.
  • NIR R, YISRAELI Y, LAMED R, SAHAR E: Sorting of viable bacteria and yeasts according to beta-galactosidaseactivity. Appl. Environ. Microbiol (1990) 56(12)3861–3866.
  • WEAVER JC, BLISS JC, HARRISON Gl, POWELL KT, WILLIAMS GB: Microdrop technology: a general method for separating cells by function and composition. Methods (1991) 2(93):234–247.
  • GOGUEN B, KERDESHA N: Clonogenic cytotoxicity testing by microdop encapsulation. Nature (1993) 363:189–190.
  • RYAN C, NGUYEN B-T, SULLIVAN S: Rapid assay for mycobacterial growth and antibiotic susceptibility using gel microdrop encapsulation.' Clin. Microbiol (1995) 33(7):1720–1726.
  • GRAY F, KENNEY JS, DUNNE JF: Secretion capture and report web: use of affinity derivatized agarose microdroplets for the selection of hybridoma cells.Immunol Methods (1995) 182:155–163.
  • WEAVER JC, MCGRATH P, ADAMS S: Gel Microdrop technology for rapid isolation of rare and high producing cells. Nature (1997) 3(5):583–585.
  • HAMMILL L, WELLES J, CARSON GR: The gel microdrop secretion assay: Identification of a low productivity subpopulation arising during the production of human antibody in CHO cells. Cytotechnology (2000) 34:27–37.
  • •Used GMD secretion assay to examine low- and non-producing hybridomas.
  • AKSELBAND Y, MOEN PT JR, MCGRATH P: Isolation of rare isotype switch variants in hybridoma cell lines using an agarose gel microdrop-based protein secretion assay. Assay Drug Dev. Technol (2003) 1(5):619–626.
  • MANZ R, ASSENMACHER M, PFLUGER E, MILTENY S,RADBRUCH A: Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc. Natl. Acad. Sci. USA (1995) 92:1921–1925.
  • ••Developed an affinity matrix to sort livecells according to their secreted molecules. Sorted hybridomas based on their antibody, and activated T lymphocytes based on their secreted cytokines.
  • FRYKMAN S, SRIENC F: Quantitating secretion rates of individual cells: design of secretion assays. Biotechnol Bioeng. (1998) 59(2):214–226.
  • HOLMES P, AL-RUBEAI M: Improved cell line development by a high throughput affinity capture surface display technique toselect for high secretors." Immunol Methods (1999) 230:141–147.
  • ••Selected high-producing NSO 6A1 usingACSD and cell size. Increased productivity by 30%.
  • TURCANU V, WILLIAMS NA: Cell identification and isolation on the basis of cytokine secretion: a novel tool for investigating immune responses. Nat. Med. (2001) 7(3):373–376.
  • CARROLL S: The selection andmonitoring of high producing recombinant cell lines using flow cytometry. PhD thesis. The University of Birmingham (2004).
  • KENNEY J, GRAY F, ANCEL MH, DUNNE J: Production of monoclonal antibodies using a secretion capture report web. Biotechnology (NV (1995) 13:787–790.
  • OHNO K, LEVIN B, MERUELO D: Cell-specific multidrug delivery system using streptavidin-protein A fusion protein. Biochem. MM. Med. (1996) 58:227–233.
  • ARIENNE KJ, OKER-BLOM C, MARJOMAKI VS, BAYER ES, WILCHECK M, KULOMAA MS: Production of biologically active recombinant avidin in baculovirus-infected insect cells. Protein Expr: Puril (1997) 9:100–108.
  • SMITH JS, KELLER JR, LOHREY NCet al.: Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens. Proc. Natl. Acad. Sci. USA (1999) 96:8855–8860.
  • GREEN NM: Avidin and streptavidin. Methods Enzymol (1990) 184:51–67.
  • WILCHEK M, BAYER EA: Introduction to avidin-biotin technology. Methods Enzymol (1990) 184:5–13.
  • ROSANO C, AROSIO P, BOLOGNESI M: The X-ray three dimensional structure of avidin. Biomol. Eng. (1990) 16:5–13.
  • CHOW AA, MOSER CA, SPEAKER TJ, OFFIT PA: Determination of efficiency of attachment of biotinylated antibodies to avidin-linked, aqueous-based microcapsules by flow cytometry. j Immunol Methods (2003) 277(1-2):135–139.
  • THIERRY AC, PERRENOUD D, PINAUD S et al.: Biotinylated synthetic chemokines: their use for the development of nonradioactive whole-cell binding assays.Biomol. Screen. (2003) 8(3):316–326.
  • SHIMIZU T, KOZONO Y, KOZONO H, ODA M, AZUMA T: Affinity maturation of secreted IgM pentamers on B cells. Int. Itninunol. (2004) 16(5):675–684.
  • STEHLIK C, KROISMAYR R, DORFLEUTNER A, BINDER BR, LIPP J: VIGR- a novel inducible adhesion family G-protein coupled receptor in endothelial cells. FEBS Lett. (2004) 569(1-3):149–155.
  • •Used cell surface biotinylation to identify VIGR.
  • ASSENMACHER M, LOHNING M, SCHEFFOLD A et al.: Commitment of individual Thl-like lymphocytes to expression of IFN-gamma versus IL-4 and IL-10: selective induction of IL-10 by sequential stimulation of naive Th cells with IL-12 and IL-4. I Immunol Methods (1998) 161(6):2825–2832.
  • BROSTERHUS H, BRINGS S, LEYENDECKERS H et al.: Enrichment and detection of live antigen-specific CD4+ and CD8+ T cells based on cytokine secretion. Eur. I Itninunol. (1999) 29:4053–4059.
  • SCHEFFOLD A, ASSENMACHER M, REINERS-SCHRAMM L, LAUSTER R, RADBRUCH A: High-sensitivity immunofluorescence for detection of the pro- and anti-inflammatory cytokines gamma interferon and interleukin-10 on the surface of cytokine-secreting cells. Nat. Med. (2000) 6(1):107–110.
  • ALON R, BAYER EA, WILCHEK M: Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin. Biochem. Biophys.Res. Commun. (1990) 170:1236–1241.
  • CHALFIE M, TU Y, EUSKIRCHEN G et al.: Green fluorescent protein as a marker for gene expression. Science (1994) 263:802–805.
  • MOSSER DD, CARON AW,BOURGET L et al.: Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products. Biotechniques (1997) 22:150–154.
  • MENG YG, LIANG J, WONG WL, CHISHOLM V: Green fluorescent protein as a second selectable marker for selection of high producing clones from transfected CHO cells. Gene (2002) 242:201–207.
  • SUBRAMIAN S, SRIENC F: Quantitative analysis of transient gene expression in mammalian cells using the green fluorescent protein. Biotechnol (1996) 49:137–151.
  • ZEYDA M, BORTH N, KUNERT R et al: Optimization of sorting conditions for the selection of stable, high-producing mammalian cell lines. Biotechnol Prog. (1999) 15:953–957.
  • CRONAN JE JR: Biotinylation of proteins in vivo. A post-translational modification to label, purify and study proteins. J. Biol. Chem. (1990) 265:10327–1033.
  • •Demonstrated site-specific biotinylation of the protein of interest.
  • REED KE, CRONANJE JR:Escherichia coil exports previously folded and biotinylated protein domains. Biol. Chem. (1991) 266:11425–11428.
  • PARROTT MB, BARRY MA: Metabolic biotinylation of recombinant in mammalian cells and in mice. Ma Thec (2000) 1:96–104.
  • CHEN G, STAHL N,YANCOPOULOS G, FANDL JP: Efficient isolation of production cell lines based on secretion levels. Cell Culture Engineering IX Conference. Cancun, Mexico (7–12 March 2004).
  • HOLASH J, DAVIS S,PAPADOPOULOS N et al: VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc. Natl. Acad. Sci. USA (2002) 99:11393–11398.
  • ECONOMIDES AN, CAROENTER LR, RUDGE JS et al.: Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat. Med. (2003) 9(1):47–52.
  • http://www.fda.gov US FDA website.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.